Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 3
1989 3
1990 8
1991 1
1992 3
1993 3
1994 4
1995 5
1996 9
1997 2
1998 9
1999 7
2000 11
2001 12
2002 6
2003 4
2004 3
2005 10
2006 8
2007 8
2008 10
2009 6
2010 8
2011 6
2012 18
2013 27
2014 45
2015 70
2016 80
2017 101
2018 113
2019 107
2020 149
2021 182
2022 161
2023 150
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.
Monzo L, Girerd N, Ferreira JP, Lamiral Z, Anker SD, Cleland JGF, Kondo T, McMurray JJV, Lam CSP, Mehra MR, Veldhuisen DJV, Greenberg B, Zannad F. Monzo L, et al. Among authors: girerd n, ferreira jp, zannad f. J Card Fail. 2024 Apr;30(4):618-623. doi: 10.1016/j.cardfail.2023.11.020. Epub 2023 Dec 18. J Card Fail. 2024. PMID: 38122924
Chronic cardiovascular-kidney disorder: a new conceptual framework.
Zoccali C, Mallamaci F, Halimi JM, Rossignol P, Sarafidis P, De Caterina R, Giugliano R, Zannad F. Zoccali C, et al. Among authors: rossignol p, zannad f. Nat Rev Nephrol. 2024 Apr;20(4):201-202. doi: 10.1038/s41581-023-00789-8. Epub 2023 Nov 15. Nat Rev Nephrol. 2024. PMID: 37968510 No abstract available.
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
Adamo M, Pagnesi M, Di Pasquale M, Ravera A, Dickstein K, Ng LL, Anker SD, Cleland JG, Filippatos GS, Lang CC, Ponikowski P, Samani NJ, Zannad F, van Veldhuisen DJ, Lipsic E, Voors A, Metra M. Adamo M, et al. Among authors: zannad f. Int J Cardiol. 2024 Mar 15;399:131664. doi: 10.1016/j.ijcard.2023.131664. Epub 2023 Dec 21. Int J Cardiol. 2024. PMID: 38141725
Home- versus centre-based EXercise InTervention in patients with Heart Failure (EXIT-HF trial): A pragmatic randomized controlled trial.
Schmidt C, Magalhães S, Gois Basilio P, Gouveia M, Teixeira M, Santos C, Tavares AI, Ferreira JP, Ribeiro F, Santos M. Schmidt C, et al. Among authors: ferreira jp. Rev Port Cardiol. 2024 Mar;43(3):149-158. doi: 10.1016/j.repc.2023.05.013. Epub 2023 Sep 15. Rev Port Cardiol. 2024. PMID: 37716466 Free article. Clinical Trial. English, Portuguese.
Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial.
Cruz M, Ferreira JP, Diaz SO, Ferrão D, Ferreira AI, Girerd N, Sampaio F, Pimenta J. Cruz M, et al. Among authors: girerd n, ferreira jp. Clin Res Cardiol. 2024 Mar;113(3):425-432. doi: 10.1007/s00392-023-02238-9. Epub 2023 Jun 8. Clin Res Cardiol. 2024. PMID: 37289237 Free article. Clinical Trial.
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
Coats AJS, Butler J, Tsutsui H, Doehner W, Filippatos G, Ferreira JP, Böhm M, Chopra VK, Verma S, Nordaby M, Iwata T, Nitta D, Ponikowski P, Zannad F, Packer M, Anker SD. Coats AJS, et al. Among authors: ferreira jp, zannad f. J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):412-424. doi: 10.1002/jcsm.13393. Epub 2023 Dec 29. J Cachexia Sarcopenia Muscle. 2024. PMID: 38158636 Free PMC article.
Risk of readmission and death after hospitalization for worsening heart failure: Role of post-discharge follow-up visits in a real-world study from the Grand Est Region of France.
Baudry G, Pereira O, Duarte K, Ferreira JP, Savarese G, Welter A, Tangre P, Lamiral Z, Agrinier N, Girerd N. Baudry G, et al. Among authors: girerd n, ferreira jp. Eur J Heart Fail. 2024 Feb;26(2):342-354. doi: 10.1002/ejhf.3103. Epub 2023 Dec 18. Eur J Heart Fail. 2024. PMID: 38059342
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
Ferreira JP, Butler J, Anker SD, Januzzi JL, Panova-Noeva M, Reese-Petersen AL, Sattar N, Schueler E, Pocock SJ, Filippatos G, Packer M, Sumin M, Zannad F; EMPEROR Committees and Investigators. Ferreira JP, et al. Among authors: zannad f. Eur J Heart Fail. 2024 Feb;26(2):274-284. doi: 10.1002/ejhf.3101. Epub 2023 Dec 28. Eur J Heart Fail. 2024. PMID: 38037709
Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial.
Santos-Ferreira D, Diaz SO, Ferreira JP, Girerd N, Pellicori P, Mariottoni B, Cosmi F, Hazebroek M, Verdonschot JAJ, Cuthbert J, Petutschnigg J, Heymans S, Staessen JA, Pieske B, Edelmann F, Clark AL, Rossignol P, Fontes-Carvalho R, Cleland JGF, Zannad F. Santos-Ferreira D, et al. Among authors: girerd n, rossignol p, ferreira jp, zannad f. ESC Heart Fail. 2024 Feb;11(1):209-218. doi: 10.1002/ehf2.14465. Epub 2023 Nov 8. ESC Heart Fail. 2024. PMID: 37939716 Free PMC article.
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction.
Streng KW, Hillege HL, Ter Maaten JM, van Veldhuisen DJ, Dickstein K, Samani NJ, Ng LL, Metra M, Filippatos GS, Ponikowski P, Zannad F, Anker SD, van der Meer P, Lang CC, Voors AA, Damman K. Streng KW, et al. Among authors: zannad f. J Cardiovasc Transl Res. 2024 Feb;17(1):3-12. doi: 10.1007/s12265-023-10356-y. Epub 2023 Feb 16. J Cardiovasc Transl Res. 2024. PMID: 36795286 Free PMC article.
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-Reduced.
Dhingra NK, Verma S, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Zaremba-Pechmann L, Böhm M, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced Trial Committees and Investigators. Dhingra NK, et al. Among authors: ferreira jp, zannad f. JACC Heart Fail. 2024 Jan;12(1):35-46. doi: 10.1016/j.jchf.2023.06.036. Epub 2023 Sep 13. JACC Heart Fail. 2024. PMID: 37715769 Free article. Clinical Trial.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
Docherty KF, McMurray JJV, Diaz R, Felker GM, Metra M, Solomon SD, Adams KF, Böhm M, Brinkley DM, Echeverria LE, Goudev AR, Howlett JG, Lund M, Ponikowski P, Yilmaz MB, Zannad F, Claggett BL, Miao ZM, Abbasi SA, Divanji P, Heitner SB, Kupfer S, Malik FI, Teerlink JR. Docherty KF, et al. Among authors: zannad f. J Card Fail. 2024 Jan;30(1):26-35. doi: 10.1016/j.cardfail.2023.08.020. Epub 2023 Sep 7. J Card Fail. 2024. PMID: 37683911 Free article. Clinical Trial.
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure.
Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Nóvoa F, Leite-Moreira A, Neves JS. Ferreira JP, et al. Among authors: zannad f. J Clin Endocrinol Metab. 2023 Dec 21;109(1):4-9. doi: 10.1210/clinem/dgad398. J Clin Endocrinol Metab. 2023. PMID: 37409733 Free article. Review.
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
Matsumoto S, Kondo T, Yang M, Campbell RT, Docherty KF, de Boer RA, Desai AS, Lam CSP, Packer M, Pitt B, Rouleau JL, Vaduganathan M, Zannad F, Zile MR, Solomon SD, Jhund PS, McMurray JJV. Matsumoto S, et al. Among authors: zannad f. Eur J Heart Fail. 2023 Dec;25(12):2202-2214. doi: 10.1002/ejhf.3044. Epub 2023 Oct 5. Eur J Heart Fail. 2023. PMID: 37771260
Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors.
Marques P, Matias P, Packer M, Vieira JT, Vasques-Nóvoa F, Sharma A, Mavrakanas TA, Friões F, Ferreira JP. Marques P, et al. Among authors: ferreira jp. Eur J Heart Fail. 2023 Dec;25(12):2191-2198. doi: 10.1002/ejhf.2992. Epub 2023 Aug 24. Eur J Heart Fail. 2023. PMID: 37559543
Heart Failure in Brazil and the Need to Measure and Take Action.
Rivas-Lasarte M, Ferreira JP. Rivas-Lasarte M, et al. Among authors: ferreira jp. J Card Fail. 2023 Nov 26:S1071-9164(23)00893-X. doi: 10.1016/j.cardfail.2023.10.485. Online ahead of print. J Card Fail. 2023. PMID: 38016621 No abstract available.
Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI).
Gargani L, Girerd N, Platz E, Pellicori P, Stankovic I, Palazzuoli A, Pivetta E, Miglioranza MH, Soliman-Aboumarie H, Agricola E, Volpicelli G, Price S, Donal E, Cosyns B, Neskovic AN; This document was reviewed by members of the 2020–2022 EACVI Scientific Documents Committee. Gargani L, et al. Among authors: girerd n. Eur Heart J Cardiovasc Imaging. 2023 Nov 23;24(12):1569-1582. doi: 10.1093/ehjci/jead169. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37450604 No abstract available.
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.
Ouwerkerk W, Belo Pereira JP, Maasland T, Emmens JE, Figarska SM, Tromp J, Koekemoer AL, Nelson CP, Nath M, Romaine SPR, Cleland JGF, Zannad F, van Veldhuisen DJ, Lang CC, Ponikowski P, Filippatos G, Anker S, Metra M, Dickstein K, Ng LL, de Boer RA, van Riel N, Nieuwdorp M, Groen AK, Stroes E, Zwinderman AH, Samani NJ, Lam CSP, Levin E, Voors AA. Ouwerkerk W, et al. Among authors: zannad f. J Am Coll Cardiol. 2023 Nov 14;82(20):1921-1931. doi: 10.1016/j.jacc.2023.08.053. J Am Coll Cardiol. 2023. PMID: 37940229
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA).
Sarafidis P, Iatridi F, Ferro C, Alexandrou ME, Fernandez-Fernandez B, Kanbay M, Mallamaci F, Nistor I, Rossignol P, Wanner C, Cozzolino M, Ortiz A. Sarafidis P, et al. Among authors: rossignol p. Clin Kidney J. 2023 Jun 24;16(11):1885-1907. doi: 10.1093/ckj/sfad139. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915899 Free PMC article.
Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients.
Brandão M, Fonseca T, Quelhas Costa R, Oliveira JC, Cyrne Carvalho H, Rodrigues P, Zannad F, Rossignol P, Ferreira MB, Ferreira JP. Brandão M, et al. Among authors: rossignol p, ferreira jp, zannad f. Clin Exp Rheumatol. 2023 Nov;41(11):2162-2166. doi: 10.55563/clinexprheumatol/ua087b. Epub 2023 Jul 13. Clin Exp Rheumatol. 2023. PMID: 37470226 Free article.
Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures.
Ferreira MB, Kobayashi M, Costa RQ, Fonseca T, Brandão M, Oliveira JC, Marinho A, Cyrne Carvalho H, Rodrigues P, Zannad F, Rossignol P, Barros AS, Ferreira JP. Ferreira MB, et al. Among authors: ferreira jp, zannad f. Scand J Rheumatol. 2023 Nov;52(6):619-626. doi: 10.1080/03009742.2023.2196781. Epub 2023 Apr 21. Scand J Rheumatol. 2023. PMID: 37083270 Free article.
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
Mark PB, Sarafidis P, Ekart R, Ferro CJ, Balafa O, Fernandez-Fernandez B, Herrington WG, Rossignol P, Del Vecchio L, Valdivielso JM, Mallamaci F, Ortiz A, Nistor I, Cozzolino M. Mark PB, et al. Among authors: rossignol p. Nephrol Dial Transplant. 2023 Oct 31;38(11):2444-2455. doi: 10.1093/ndt/gfad112. Nephrol Dial Transplant. 2023. PMID: 37230946 Free PMC article. Review.
Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach.
de Gonzalo-Calvo D, Martinez-Camblor P, Belmonte T, Barbé F, Duarte K, Cowie MR, Angermann CE, Korte A, Riedel I, Labus J, Koenig W, Zannad F, Thum T, Bär C. de Gonzalo-Calvo D, et al. Among authors: zannad f. J Transl Med. 2023 Oct 20;21(1):742. doi: 10.1186/s12967-023-04558-w. J Transl Med. 2023. PMID: 37864227 Free PMC article.
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.
Cosentino F, Verma S, Ambery P, Treppendahl MB, van Eickels M, Anker SD, Cecchini M, Fioretto P, Groop PH, Hess D, Khunti K, Lam CSP, Richard-Lordereau I, Lund LH, McGreavy P, Newsome PN, Sattar N, Solomon S, Weidinger F, Zannad F, Zeiher A. Cosentino F, et al. Among authors: zannad f. Eur Heart J. 2023 Oct 14;44(39):4141-4156. doi: 10.1093/eurheartj/ehad445. Eur Heart J. 2023. PMID: 37448181
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
Khan MS, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Chopra VK, Piña IL, Böhm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Peil B, Zannad F, Packer M, Butler J. Khan MS, et al. Among authors: ferreira jp, zannad f. J Card Fail. 2023 Oct;29(10):1345-1354. doi: 10.1016/j.cardfail.2023.06.024. Epub 2023 Aug 8. J Card Fail. 2023. PMID: 37558088 Free article.
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE.
Ferreira JP, Blatchford JP, Teerlink JR, Kosiborod MN, Angermann CE, Biegus J, Collins SP, Tromp J, Nassif ME, Psotka MA, Comin-Colet J, Mentz RJ, Brueckmann M, Nordaby M, Ponikowski P, Voors AA. Ferreira JP, et al. Eur J Heart Fail. 2023 Oct;25(10):1797-1805. doi: 10.1002/ejhf.2982. Epub 2023 Aug 22. Eur J Heart Fail. 2023. PMID: 37540060 Free article. Clinical Trial.
Role of aldosterone in mid- and long-term left ventricular remodelling after acute myocardial infarction: The REMI study.
Monzo L, Huttin O, Ferreira JP, Lamiral Z, Bozec E, Beaumont M, Micard E, Baudry G, Marie PY, Eschalier R, Rossignol P, Zannad F, Girerd N. Monzo L, et al. Among authors: baudry g, girerd n, rossignol p, ferreira jp, zannad f. Eur J Heart Fail. 2023 Oct;25(10):1742-1752. doi: 10.1002/ejhf.2986. Epub 2023 Aug 24. Eur J Heart Fail. 2023. PMID: 37530453 Free article.
Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation.
Baudry G, Coutance G, Dorent R, Bauer F, Blanchart K, Boignard A, Chabanne C, Delmas C, D'Ostrevy N, Epailly E, Gariboldi V, Gaudard P, Goéminne C, Grosjean S, Guihaire J, Guillemain R, Mattei M, Nubret K, Pattier S, Vermes E, Sebbag L, Duarte K, Girerd N. Baudry G, et al. Among authors: girerd n. ESC Heart Fail. 2023 Oct;10(5):2843-2852. doi: 10.1002/ehf2.14467. Epub 2023 Jul 5. ESC Heart Fail. 2023. PMID: 37408178 Free PMC article.
Machine Learning-Based Phenogrouping in MVP Identifies Profiles Associated With Myocardial Fibrosis and Cardiovascular Events.
Huttin O, Girerd N, Jobbe-Duval A, Constant Dit Beaufils AL, Senage T, Filippetti L, Cueff C, Duarte K, Fraix A, Piriou N, Mandry D, Pace N, Le Scouarnec S, Capoulade R, Echivard M, Sellal JM, Marrec M, Beaumont M, Hossu G, Trochu JN, Sadoul N, Marie PY, Guenancia C, Schott JJ, Roussel JC, Serfaty JM, Selton-Suty C, Le Tourneau T. Huttin O, et al. Among authors: girerd n. JACC Cardiovasc Imaging. 2023 Oct;16(10):1271-1284. doi: 10.1016/j.jcmg.2023.03.009. Epub 2023 May 17. JACC Cardiovasc Imaging. 2023. PMID: 37204382 Free article.
Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts.
Girerd N, Leclercq C, Hanon O, Bayés-Genís A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F. Girerd N, et al. Rev Esp Cardiol (Engl Ed). 2023 Oct;76(10):813-820. doi: 10.1016/j.rec.2023.03.005. Epub 2023 Mar 11. Rev Esp Cardiol (Engl Ed). 2023. PMID: 36914024 Free article. Review. English, Spanish.
Layer myocardial strain is the most heritable echocardiographic trait.
Huttin O, Xhaard C, Dandine-Roulland C, Le Floch E, Bacq-Daian D, Lamiral Z, Bozec E, Deleuze JF, Zannad F, Rossignol P, Girerd N. Huttin O, et al. Among authors: girerd n, rossignol p, zannad f. Eur Heart J Cardiovasc Imaging. 2023 Sep 26;24(10):1394-1403. doi: 10.1093/ehjci/jead146. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37352124 Free article.
conTemporary reflectiOns regarding heart failure manaGEmenT - How to ovERcome the PorTuguese barriers (TOGETHER-PT).
Silva-Cardoso J, Santos J, Araújo I, Andrade A, Morais Sarmento P, Santos P, Moura B, Marques I, Peres M, Ferreira JP, Agostinho J, Pimenta J. Silva-Cardoso J, et al. Among authors: ferreira jp. Rev Port Cardiol. 2023 Sep 7:S0870-2551(23)00400-6. doi: 10.1016/j.repc.2023.05.012. Online ahead of print. Rev Port Cardiol. 2023. PMID: 37689388 Free article. English, Portuguese.
NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance.
Bonnard B, El Moghrabi S, Ueda K, Lattenist L, Soulie M, López-Andrés N, Xhaard C, Shimosawa T, Rossignol P, Jaisser F. Bonnard B, et al. Among authors: rossignol p. Hypertension. 2023 Sep;80(9):1860-1870. doi: 10.1161/HYPERTENSIONAHA.123.21156. Epub 2023 Jun 28. Hypertension. 2023. PMID: 37377014 Free article.
Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis.
Angélico-Gonçalves A, Leite AR, Neves JS, Saraiva F, Brochado L, Oliveira AC, Butler J, Packer M, Zannad F, Vasques-Nóvoa F, Leite-Moreira A, Ferreira JP. Angélico-Gonçalves A, et al. Among authors: ferreira jp, zannad f. Int J Cardiol. 2023 Sep 1;386:65-73. doi: 10.1016/j.ijcard.2023.05.032. Epub 2023 May 19. Int J Cardiol. 2023. PMID: 37211049 Free article.
Health status across major subgroups of patients with heart failure and preserved ejection fraction.
Siddiqi TJ, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Böhm M, Brueckmann M, Chopra VK, Iwata T, Januzzi J, Piña IL, Ponikowski P, Senni M, Vedin O, Verma S, Zhang Y, Zannad F, Packer M, Butler J. Siddiqi TJ, et al. Among authors: ferreira jp, zannad f. Eur J Heart Fail. 2023 Sep;25(9):1623-1631. doi: 10.1002/ejhf.2831. Epub 2023 Apr 4. Eur J Heart Fail. 2023. PMID: 36974746
Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.
Sharma A, Caldeira D, Razaghizad A, Pinto FJ, van Veldhuisen DJ, Mehra MR, Lam CSP, Cleland J, Anker SD, Greenberg B, Ferreira JP, Zannad F. Sharma A, et al. Among authors: ferreira jp, zannad f. BMJ Open. 2023 Aug 11;13(8):e068865. doi: 10.1136/bmjopen-2022-068865. BMJ Open. 2023. PMID: 37567750 Free PMC article. Clinical Trial.
Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.
Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Filippatos G, Gustafsson F, Lam CSP, Lund LH, Mentz RJ, Pieske B, Ponikowski P, Senni M, Skopicki N, Voors AA, Zannad F, Zieroth S, Butler J. Greene SJ, et al. Among authors: zannad f. J Am Coll Cardiol. 2023 Aug 8;82(6):559-571. doi: 10.1016/j.jacc.2023.04.057. J Am Coll Cardiol. 2023. PMID: 37532426 Free article. Review.
Global Comparison of Readmission Rates for Patients With Heart Failure.
Foroutan F, Rayner DG, Ross HJ, Ehler T, Srivastava A, Shin S, Malik A, Benipal H, Yu C, Alexander Lau TH, Lee JG, Rocha R, Austin PC, Levy D, Ho JE, McMurray JJV, Zannad F, Tomlinson G, Spertus JA, Lee DS. Foroutan F, et al. Among authors: zannad f. J Am Coll Cardiol. 2023 Aug 1;82(5):430-444. doi: 10.1016/j.jacc.2023.05.040. J Am Coll Cardiol. 2023. PMID: 37495280
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trial.
Monzo L, Girerd N, Duarte K, Ferreira JP, McMurray JJV, van Veldhuisen DJ, Swedberg K, Pocock SJ, Pitt B, Zannad F. Monzo L, et al. Among authors: girerd n, ferreira jp, zannad f. Eur J Heart Fail. 2023 Aug;25(8):1444-1449. doi: 10.1002/ejhf.2952. Epub 2023 Jul 7. Eur J Heart Fail. 2023. PMID: 37370197 Free article. Clinical Trial.
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial.
Böhm M, Butler J, Krawczyk M, Mahfoud F, Haring B, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Ofstad AP, Schüler E, Wanner C, Verma S, Packer M, Anker SD; EMPEROR-Preserved Trial Committees and Investigators. Böhm M, et al. Among authors: ferreira jp. Eur J Heart Fail. 2023 Aug;25(8):1375-1383. doi: 10.1002/ejhf.2922. Epub 2023 Jun 27. Eur J Heart Fail. 2023. PMID: 37278451 Free article. Clinical Trial.
A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trial.
Kobayashi M, Huttin O, Ferreira JP, Duarte K, González A, Heymans S, Verdonschot JAJ, Brunner-La Rocca HP, Pellicori P, Clark AL, Petutschnigg J, Edelmann F, Cleland JG, Rossignol P, Zannad F, Girerd N; HOMAGE Trial Committees and Investigators. Kobayashi M, et al. Among authors: girerd n, rossignol p, ferreira jp, zannad f. Eur J Heart Fail. 2023 Aug;25(8):1284-1289. doi: 10.1002/ejhf.2859. Epub 2023 Apr 26. Eur J Heart Fail. 2023. PMID: 37062878
Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial.
Sharma A, Ferreira JP, Zannad F, Pocock SJ, Filippatos G, Pfarr E, Petrini M, Kraus BJ, Wanner C, Packer M, Butler J, Anker SD. Sharma A, et al. Among authors: ferreira jp, zannad f. Eur J Heart Fail. 2023 Aug;25(8):1337-1348. doi: 10.1002/ejhf.2857. Epub 2023 May 4. Eur J Heart Fail. 2023. PMID: 37062851 Clinical Trial.
Electrocardiographic characteristics of right-bundle-branch-block premature ventricular complexes predicting absence of left ventricular scar in athletes with apparently structural normal heart.
Calò L, Panattoni G, Tatangelo M, Brunetti G, Graziano F, Monzo L, Danza ML, Fedele E, Grieco D, Crescenzi C, Rebecchi M, Stazi A, Bressi E, De Ruvo E, Golia P, Gaita F, Corrado D, Zorzi A. Calò L, et al. Among authors: monzo l. Europace. 2023 Jul 4;25(7):euad217. doi: 10.1093/europace/euad217. Europace. 2023. PMID: 37466354 Free PMC article.
Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation.
Kondo T, Jering KS, Jhund PS, Anand IS, Desai AS, Lam CSP, Maggioni AP, Martinez FA, Packer M, Petrie MC, Pfeffer MA, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV. Kondo T, et al. Among authors: zannad f. Circ Heart Fail. 2023 Jul;16(7):e010377. doi: 10.1161/CIRCHEARTFAILURE.122.010377. Epub 2023 Jun 23. Circ Heart Fail. 2023. PMID: 37350280 Clinical Trial.
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
Schrage B, Lund LH, Benson L, Braunschweig F, Ferreira JP, Dahlström U, Metra M, Rosano GMC, Savarese G. Schrage B, et al. Among authors: ferreira jp. Eur J Heart Fail. 2023 Jul;25(7):1132-1144. doi: 10.1002/ejhf.2928. Epub 2023 Jun 27. Eur J Heart Fail. 2023. PMID: 37317585 Free article.
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial.
Butler J, Usman MS, Filippatos G, Ferreira JP, Böhm M, Brueckmann M, Januzzi JL, Kaul S, Piña IL, Ponikowski P, Senni M, Sumin M, Verma S, Zaremba-Pechmann L, Pocock SJ, Packer M, Anker S. Butler J, et al. Among authors: ferreira jp. JAMA Cardiol. 2023 Jul 1;8(7):640-649. doi: 10.1001/jamacardio.2023.1090. JAMA Cardiol. 2023. PMID: 37223933 Free PMC article.
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled.
Verma S, Dhingra NK, Bonaca MP, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Iwata T, Nordaby M, Brueckmann M, Pocock SJ, Packer M; EMPEROR Trials Committees and Investigators. Verma S, et al. Among authors: ferreira jp. Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1334-1337. doi: 10.1161/ATVBAHA.123.319156. Epub 2023 May 18. Arterioscler Thromb Vasc Biol. 2023. PMID: 37199158 Free PMC article. No abstract available.
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation.
Filippatos G, Farmakis D, Butler J, Zannad F, Ferreira JP, Ofstad AP, Iwata T, Brueckmann M, Pocock SJ, Packer M, Anker SD; EMPEROR-Preserved Trial Committees and Investigators. Filippatos G, et al. Among authors: ferreira jp, zannad f. Eur J Heart Fail. 2023 Jul;25(7):970-977. doi: 10.1002/ejhf.2861. Epub 2023 May 8. Eur J Heart Fail. 2023. PMID: 37062866 Clinical Trial.
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
Patel S, Lam PH, Kanonidis EI, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A. Patel S, et al. Among authors: rossignol p. Am J Med. 2023 Jul;136(7):677-686. doi: 10.1016/j.amjmed.2023.03.017. Epub 2023 Apr 3. Am J Med. 2023. PMID: 37019372
Hypertension management in patients with cardiovascular comorbidities.
Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, Parati G, Rossignol P, Schlaich MP, Teo KK, Townsend RR, Tsioufis C, Weber MA, Weber T, Böhm M. Lauder L, et al. Among authors: rossignol p. Eur Heart J. 2023 Jun 20;44(23):2066-2077. doi: 10.1093/eurheartj/ehac395. Eur Heart J. 2023. PMID: 36342266 Review.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S; COVI-DOSE investigators. Zuily S, et al. Among authors: rossignol p. EClinicalMedicine. 2023 Jun;60:102031. doi: 10.1016/j.eclinm.2023.102031. Epub 2023 Jun 9. EClinicalMedicine. 2023. PMID: 37350990 Free PMC article.
Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study).
Lopez-Sublet M, Merkling T, Girerd N, Xhaard C, Flahault A, Bozec E, Leroy C, Fujikawa T, Vaag AA, Mebazaa A, Kistorp CM, Heude B, Boivin JM, Zannad F, Wagner S, Rossignol P. Lopez-Sublet M, et al. Among authors: girerd n, wagner s, rossignol p, zannad f, boivin jm. J Hypertens. 2023 Jun 1;41(6):1040-1050. doi: 10.1097/HJH.0000000000003438. Epub 2023 Apr 17. J Hypertens. 2023. PMID: 37071444 Free article.
Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.
O'Lone E, Apple FS, Burton JO, Caskey FJ, Craig JC, deFilippi CR, Forfang D, Hicks KA, Jha V, Mahaffey KW, Mark PB, Rossignol P, Scholes-Robertson N, Jaure A, Viecelli AK, Wang AY, Wheeler DC, White D, Winkelmayer WC, Herzog CA. O'Lone E, et al. Among authors: rossignol p. Kidney Int. 2023 Jun;103(6):1028-1037. doi: 10.1016/j.kint.2023.02.033. Epub 2023 Apr 5. Kidney Int. 2023. PMID: 37023851 Free article.
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials.
Ferreira JP, Saraiva F, Sharma A, Vasques-Nóvoa F, Angélico-Gonçalves A, Leite AR, Borges-Canha M, Carvalho D, Packer M, Zannad F, Leite-Moreira A, Neves JS. Ferreira JP, et al. Among authors: zannad f. Diabetes Obes Metab. 2023 Jun;25(6):1495-1502. doi: 10.1111/dom.14997. Epub 2023 Feb 20. Diabetes Obes Metab. 2023. PMID: 36722252 Free article.
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
Butler J, Packer M, Siddiqi TJ, Böhm M, Brueckmann M, Januzzi JL, Verma S, Gergei I, Iwata T, Wanner C, Ferreira JP, Pocock SJ, Filippatos G, Anker SD, Zannad F. Butler J, et al. Among authors: ferreira jp, zannad f. J Am Coll Cardiol. 2023 May 16;81(19):1902-1914. doi: 10.1016/j.jacc.2023.03.390. J Am Coll Cardiol. 2023. PMID: 37164523 Free article.
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.
Girerd N, Levy D, Duarte K, Ferreira JP, Ballantyne C, Collier T, Pizard A, Björkman J, Butler J, Clark A, Cleland JG, Delles C, Diez J, González A, Hazebroek M, Ho J, Huby AC, Hwang SJ, Latini R, Mariottoni B, Mebazaa A, Pellicori P, Sattar N, Sever P, Staessen JA, Verdonschot J, Heymans S, Rossignol P, Zannad F. Girerd N, et al. Among authors: rossignol p, ferreira jp, zannad f. Circ Heart Fail. 2023 May;16(5):e009694. doi: 10.1161/CIRCHEARTFAILURE.122.009694. Epub 2023 May 16. Circ Heart Fail. 2023. PMID: 37192292 Free PMC article.
Bempedoic acid: what prospective uses?
Jacomelli I, Monzo L, Panattoni G, Lanzillo C, Rebecchi M, Calò L. Jacomelli I, et al. Among authors: monzo l. Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C109-C111. doi: 10.1093/eurheartjsupp/suad012. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125277 Free PMC article.
Optimal management of patients after acute coronary syndrome.
Panattoni G, Monzo L, Gugliotta M, Proietti G, Tatangelo M, Jacomelli I, Zimbardo G, Meringolo F, Fedele E, Calò L. Panattoni G, et al. Among authors: monzo l. Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C84-C89. doi: 10.1093/eurheartjsupp/suad039. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125273 Free PMC article.
The win ratio method in heart failure trials: lessons learnt from EMPULSE.
Pocock SJ, Ferreira JP, Collier TJ, Angermann CE, Biegus J, Collins SP, Kosiborod M, Nassif ME, Ponikowski P, Psotka MA, Teerlink JR, Tromp J, Gregson J, Blatchford JP, Zeller C, Voors AA. Pocock SJ, et al. Among authors: ferreira jp. Eur J Heart Fail. 2023 May;25(5):632-641. doi: 10.1002/ejhf.2853. Epub 2023 Apr 23. Eur J Heart Fail. 2023. PMID: 37038330 Clinical Trial.
Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation.
Salib M, Girerd N, Simon A, Kearney-Schwartz A, Duarte K, Leroy C, Rossignol P, Benetos A, Frimat L, Girerd S. Salib M, et al. Among authors: girerd n, rossignol p. Ann Transplant. 2023 Apr 25;28:e938137. doi: 10.12659/AOT.938137. Ann Transplant. 2023. PMID: 37095693 Free PMC article.
Treating chronic kidney disease to reduce cardiovascular risk.
Cice G, Monzo L, Calò L. Cice G, et al. Among authors: monzo l. Eur Heart J Suppl. 2023 Apr 21;25(Suppl B):B50-B54. doi: 10.1093/eurheartjsupp/suad067. eCollection 2023 Apr. Eur Heart J Suppl. 2023. PMID: 37091635 Free PMC article.
Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis.
Lukovic D, Hasimbegovic E, Winkler J, Mester-Tonczar J, Müller-Zlabinger K, Han E, Spannbauer A, Traxler-Weidenauer D, Bergler-Klein J, Pavo N, Goliasch G, Batkai S, Thum T, Zannad F, Gyöngyösi M. Lukovic D, et al. Among authors: zannad f. Int J Mol Sci. 2023 Apr 18;24(8):7461. doi: 10.3390/ijms24087461. Int J Mol Sci. 2023. PMID: 37108624 Free PMC article.
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
Ferreira JP, Cleland JG, Girerd N, Rossignol P, Pellicori P, Cosmi F, Mariottoni B, González A, Diez J, Solomon SD, Claggett B, Pfeffer MA, Pitt B, Petutschnigg J, Pieske B, Edelmann F, Zannad F. Ferreira JP, et al. Among authors: girerd n, rossignol p, zannad f. Int J Cardiol. 2023 Apr 15;377:86-88. doi: 10.1016/j.ijcard.2023.01.088. Epub 2023 Feb 2. Int J Cardiol. 2023. PMID: 36738846 Free article.
Myocardial deformation in malignant mitral valve prolapse: A shifting paradigm to dynamic mitral valve-ventricular interactions.
Pace N, Sellal JM, Venner C, Mandry D, Marie PY, Filippetti L, Echivard M, Fraix A, Girerd N, Lamiral Z, De Chillou C, Sadoul N, Selton-Suty C, Huttin O. Pace N, et al. Among authors: girerd n. Front Cardiovasc Med. 2023 Apr 12;10:1140216. doi: 10.3389/fcvm.2023.1140216. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37123476 Free PMC article.
Patient-reported outcome measures and patient engagement in heart failure clinical trials: multi-stakeholder perspectives.
Zannad F, Alikhaani J, Alikhaani S, Butler J, Gordon J, Jensen K, Khatib R, Mantovani L, Martinez R, Moore WF, Murakami M, Roessig L, Stockbridge N, Van Spall HGC, Yancy C, Spertus JA. Zannad F, et al. Eur J Heart Fail. 2023 Apr;25(4):478-487. doi: 10.1002/ejhf.2828. Epub 2023 Mar 22. Eur J Heart Fail. 2023. PMID: 36924142 Free article. Review.
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial.
Carson P, Teerlink JR, Komajda M, Anand I, Anker SD, Butler J, Doehner W, Ferreira JP, Filippatos G, Haass M, Miller A, Pehrson S, Pocock SJ, Schnaidt S, Schnee JM, Zannad F, Packer M. Carson P, et al. Among authors: ferreira jp, zannad f. JACC Heart Fail. 2023 Apr;11(4):407-417. doi: 10.1016/j.jchf.2022.11.017. Epub 2023 Feb 1. JACC Heart Fail. 2023. PMID: 36881400 Free article.
Door-to-furosemide time and clinical outcomes in acute heart failure.
Marques P, Brito MT, Vasques-Nóvoa F, Ferreira JP, Jardim AL, Gouveia R, Besteiro B, Vieira JT, Gomes F, Leite-Moreira A, Bettencourt P, Almeida J, Friões F. Marques P, et al. Among authors: ferreira jp. Eur J Emerg Med. 2023 Apr 1;30(2):85-90. doi: 10.1097/MEJ.0000000000001006. Epub 2023 Feb 1. Eur J Emerg Med. 2023. PMID: 36735452 Free article.
Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial.
H Brandt-Jacobsen N, Johansen ML, Rasmussen JJ, Dalsgaard M, Kumler T, Faber J, Rossignol P, Schou M, Kistorp C. H Brandt-Jacobsen N, et al. Among authors: rossignol p. BMC Cardiovasc Disord. 2023 Mar 31;23(1):175. doi: 10.1186/s12872-023-03183-1. BMC Cardiovasc Disord. 2023. PMID: 37003987 Free PMC article. Clinical Trial.
Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: a report from the 2020 Kidney Disease Clinical Trialists meeting.
Lazzareschi D, Mehta RL, Dember LM, Bernholz J, Turan A, Sharma A, Kheterpal S, Parikh CR, Ali O, Schulman IH, Ryan A, Feng J, Simon N, Pirracchio R, Rossignol P, Legrand M. Lazzareschi D, et al. Among authors: rossignol p. Nephrol Dial Transplant. 2023 Mar 31;38(4):834-844. doi: 10.1093/ndt/gfac003. Nephrol Dial Transplant. 2023. PMID: 35022767 Free PMC article. Review.
Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial).
Ferreira JP, Cleland JGF, Girerd N, Pellicori P, Hazebroek MR, Verdonschot J, Collier TJ, Petutschnigg J, Clark AL, Staessen JA, Heymans S, Rossignol P, Zannad F. Ferreira JP, et al. Among authors: girerd n, rossignol p, zannad f. Am J Cardiol. 2023 Mar 15;191:39-42. doi: 10.1016/j.amjcard.2022.12.016. Epub 2023 Jan 10. Am J Cardiol. 2023. PMID: 36634548 Free article. Clinical Trial.
Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptions.
Jankowska EA, Liu PP, Cowie MR, Groenhart M, Cobey KD, Howlett J, Komajda M, Lund LH, Magaña Serrano JA, Mourilhe-Rocha R, Rosano GMC, Saldarriaga C, Schwartzmann PV, Zannad F, Zhang J, Zhang Y, Coats AJS. Jankowska EA, et al. Among authors: zannad f. Eur J Heart Fail. 2023 Mar;25(3):364-372. doi: 10.1002/ejhf.2798. Eur J Heart Fail. 2023. PMID: 36823770 Free article.
Associations of childhood adiposity with adult intima-media thickness and inflammation: a 20-year longitudinal population-based cohort.
Fujikawa T, Kobayashi M, Wagner S, Duarte K, Scherdel P, Heude B, Dupont V, Bozec E, Bresso E, Zannad F, Rossignol P, Girerd N. Fujikawa T, et al. Among authors: girerd n, wagner s, rossignol p, zannad f. J Hypertens. 2023 Mar 1;41(3):402-410. doi: 10.1097/HJH.0000000000003343. Epub 2022 Dec 22. J Hypertens. 2023. PMID: 36728849 Free article.
Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC).
AlSahow A, AbdulShafy M, Al-Ghamdi S, AlJoburi H, AlMogbel O, Al-Rowaie F, Attallah N, Bader F, Hussein H, Hassan M, Taha K, Weir MR, Zannad F. AlSahow A, et al. Among authors: zannad f. J Clin Hypertens (Greenwich). 2023 Mar;25(3):251-258. doi: 10.1111/jch.14633. Epub 2023 Jan 30. J Clin Hypertens (Greenwich). 2023. PMID: 36715554 Free PMC article. Review.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Curtain JP, Adamson C, Kondo T, Butt JH, Desai AS, Zannad F, Rouleau JL, Rohde LE, Kober L, Anand IS, van Veldhuisen DJ, Zile MR, Lefkowitz MP, Solomon SD, Packer M, Petrie MC, Jhund PS, McMurray JJV. Curtain JP, et al. Among authors: zannad f. Eur Heart J. 2023 Feb 21;44(8):668-677. doi: 10.1093/eurheartj/ehac801. Eur Heart J. 2023. PMID: 36632831 Clinical Trial.
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.
Agarwal R, Pitt B, Palmer BF, Kovesdy CP, Burgess E, Filippatos G, Małyszko J, Ruilope LM, Rossignol P, Rossing P, Pecoits-Filho R, Anker SD, Joseph A, Lawatscheck R, Wilson D, Gebel M, Bakris GL. Agarwal R, et al. Among authors: rossignol p. Clin Kidney J. 2022 Oct 30;16(2):293-302. doi: 10.1093/ckj/sfac234. eCollection 2023 Feb. Clin Kidney J. 2022. PMID: 36864892 Free PMC article.
Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial.
Bartholdy KV, Johansen ND, Landler N, Skaarup KG, Jensen J, Bressendorff I, Schou M, Christensen J, Feldt-Rasmussen B, Vaduganathan M, Solomon S, Haynes R, Persson F, Rossing P, Køber L, Zannad F, Hansen D, Biering-Sørensen T. Bartholdy KV, et al. Among authors: zannad f. Kidney360. 2023 Feb 1;4(2):143-149. doi: 10.34067/KID.0006982022. Epub 2022 Dec 18. Kidney360. 2023. PMID: 36649484 Free PMC article. Clinical Trial.
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Bhm M, Anker S, Mahfoud F, Lauder L, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Saloustros I, Schler E, Wanner C, Zannad F, Packer M, Butler J. Bhm M, et al. Among authors: ferreira jp, zannad f. Eur Heart J. 2023 Feb 1;44(5):396-407. doi: 10.1093/eurheartj/ehac693. Eur Heart J. 2023. PMID: 36478225 Free PMC article. Clinical Trial.
Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey.
Fauvel C, Bonnet G, Mullens W, Giraldo CIS, Mežnar AZ, Barasa A, Tokmakova M, Shchendrygina A, Costa FM, Mapelli M, Zemrak F, Tops LF, Jakus N, Sultan A, Bahouth F, Hadjseyd CE, Salvat M, Anselmino M, Messroghli D, Weberndörfer V, Giverts I, Bochaton T, Courand PY, Berthelot E, Legallois D, Beauvais F, Bauer F, Lamblin N, Damy T, Girerd N, Sebbag L, Pezel T, Cohen-Solal A, Rosano G, Roubille F, Mewton N. Fauvel C, et al. Among authors: girerd n. Eur J Heart Fail. 2023 Feb;25(2):213-222. doi: 10.1002/ejhf.2743. Epub 2022 Nov 23. Eur J Heart Fail. 2023. PMID: 36404398 Free article.
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
Januzzi JL Jr, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Lewis GD, Marwick TH, Rosenstock J, Tang WHW, Zannad F, Lawson F, Perfetti R, Urbinati A. Januzzi JL Jr, et al. Among authors: zannad f. Am Heart J. 2023 Feb;256:25-36. doi: 10.1016/j.ahj.2022.11.003. Epub 2022 Nov 11. Am Heart J. 2023. PMID: 36372245 Free article. Clinical Trial.
Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial.
Ferreira JP, Cleland JGF, Girerd N, Pellicori P, Hazebroek MR, Verdonschot J, Collier TJ, Petutschnigg J, Clark AL, Staessen JA, Heymans S, Zannad F, Rossignol P. Ferreira JP, et al. Among authors: girerd n, rossignol p, zannad f. Clin Res Cardiol. 2023 Feb;112(2):330-332. doi: 10.1007/s00392-022-02116-w. Epub 2022 Oct 24. Clin Res Cardiol. 2023. PMID: 36279002 Free article. No abstract available.
Albuminuria as a marker of systemic congestion in patients with heart failure.
Boorsma EM, Ter Maaten JM, Damman K, van Essen BJ, Zannad F, van Veldhuisen DJ, Samani NJ, Dickstein K, Metra M, Filippatos G, Lang CC, Ng L, Anker SD, Cleland JG, Pellicori P, Gansevoort RT, Heerspink HJL, Voors AA, Emmens JE. Boorsma EM, et al. Among authors: zannad f. Eur Heart J. 2023 Feb 1;44(5):368-380. doi: 10.1093/eurheartj/ehac528. Eur Heart J. 2023. PMID: 36148485 Free PMC article.
Albuminuria and Heart Failure: JACC State-of-the-Art Review.
Khan MS, Shahid I, Anker SD, Fonarow GC, Fudim M, Hall ME, Hernandez A, Morris AA, Shafi T, Weir MR, Zannad F, Bakris GL, Butler J. Khan MS, et al. Among authors: zannad f. J Am Coll Cardiol. 2023 Jan 24;81(3):270-282. doi: 10.1016/j.jacc.2022.10.028. J Am Coll Cardiol. 2023. PMID: 36653095 Free article. Review.
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, Mark PB, Persu A, Rossignol P, Ruilope LM, Schmieder RE, Valdivielso JM, Del Vecchio L, Zoccali C, Mallamaci F, Sarafidis P; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney Working Group of the European Society of Hypertension (ESH). Ortiz A, et al. Among authors: rossignol p. Nephrol Dial Transplant. 2023 Jan 23;38(1):10-25. doi: 10.1093/ndt/gfab167. Nephrol Dial Transplant. 2023. PMID: 33944938 Free article.
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause.
Khan MS, Butler J, Anker SD, Filippatos G, Ferreira JP, Pocock SJ, Januzzi JL, Piña IL, Böhm M, Ponikowski P, Verma S, Brueckmann M, Vedin O, Zeller C, Zannad F, Packer M. Khan MS, et al. Among authors: ferreira jp, zannad f. J Am Heart Assoc. 2023 Jan 3;12(1):e027652. doi: 10.1161/JAHA.122.027652. Epub 2022 Dec 24. J Am Heart Assoc. 2023. PMID: 36565199 Free PMC article. Clinical Trial.
Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled.
Verma S, Dhingra NK, Butler J, Anker SD, Pedro Ferreira J, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Pfarr E, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Pooled Trial Committees and Investigators. Verma S, et al. Among authors: zannad f. Circulation. 2023 Jan 3;147(1):101-104. doi: 10.1161/CIRCULATIONAHA.122.062644. Epub 2022 Nov 7. Circulation. 2023. PMID: 36342827 No abstract available.
Clinical Features, Socioeconomic Status, Management, and Outcomes of Acute Heart Failure: PEACE MENA Registry Phase I Results.
AlBackr H, Alhabib KF, Sulaiman K, Jamee A, Sobhy M, Benkhedda S, Dada S, Hammoudeh A, Gamra H, Al-Motarreb A, Alkindi F, Amin MI, Yousif MG, Farhan HA, Fellat N, Almahmeed W, Jarallah MA, Panduranga P, Abdelhamid M, Ghaly I, Djermane D, Chibane A, Skouri H, Jarrah M, Amor H, Alsagheer NK, Hozayen MA, Ahmed HS, Ali M, Ullah A, Saleh AA, Zannad F. AlBackr H, et al. Among authors: zannad f. Curr Vasc Pharmacol. 2023;21(4):257-267. doi: 10.2174/1570161121666230525111259. Curr Vasc Pharmacol. 2023. PMID: 37231723
Fibrosis Biomarkers Predict Cardiac Reverse Remodeling.
O'Meara E, Zannad F. O'Meara E, et al. Among authors: zannad f. JACC Heart Fail. 2023 Jan;11(1):73-75. doi: 10.1016/j.jchf.2022.11.011. JACC Heart Fail. 2023. PMID: 36599552 Free article. No abstract available.
Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review.
Wilson GJ, Van K, O'Lone E, Tong A, Craig JC, Sautenet B, Budde K, Forfang D, Gill J, Herrington WG, Jafar TH, Johnson DW, Krane V, Levin A, Malyszko J, Rossignol P, Sawinski D, Scholes-Robertons N, Strippoli G, Wang A, Winkelmayer WC, Hawley CM, Viecelli AK. Wilson GJ, et al. Among authors: rossignol p. Transplant Direct. 2022 Dec 7;9(1):e1398. doi: 10.1097/TXD.0000000000001398. eCollection 2023 Jan. Transplant Direct. 2022. PMID: 36518792 Free PMC article.
Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced.
Anker SD, Khan MS, Butler J, Ofstad AP, Peil B, Pfarr E, Doehner W, Sattar N, Coats AJS, Filippatos G, Ferreira JP, Zannad F, Pocock S, Packer M. Anker SD, et al. Among authors: ferreira jp, zannad f. Eur J Heart Fail. 2023 Jan;25(1):117-127. doi: 10.1002/ejhf.2728. Epub 2022 Nov 24. Eur J Heart Fail. 2023. PMID: 36325584 Free PMC article. Clinical Trial.
Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials.
Ferreira JP, Cleland JG, Girerd N, Bozec E, Rossignol P, Pellicori P, Cosmi F, Mariottoni B, Solomon SD, Pitt B, Pfeffer MA, Shah AM, Petutschnigg J, Pieske B, Edelmann F, Zannad F. Ferreira JP, et al. Among authors: girerd n, rossignol p, zannad f. Eur J Heart Fail. 2023 Jan;25(1):108-113. doi: 10.1002/ejhf.2726. Epub 2022 Nov 9. Eur J Heart Fail. 2023. PMID: 36303266 Free article.
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE, Tromp J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Salsali A, Blatchford JP, Ponikowski P. Biegus J, et al. Among authors: ferreira jp. Eur Heart J. 2023 Jan 1;44(1):41-50. doi: 10.1093/eurheartj/ehac530. Eur Heart J. 2023. PMID: 36254693 Free PMC article. Clinical Trial.
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial.
Neves JS, Vasques-Nóvoa F, Borges-Canha M, Leite AR, Sharma A, Carvalho D, Packer M, Zannad F, Leite-Moreira A, Ferreira JP. Neves JS, et al. Among authors: ferreira jp, zannad f. Diabetes Obes Metab. 2023 Jan;25(1):189-197. doi: 10.1111/dom.14862. Epub 2022 Sep 21. Diabetes Obes Metab. 2023. PMID: 36082522 Free PMC article. Clinical Trial.
Assessment of filling pressures and fluid overload in heart failure: an updated perspective.
de la Espriella R, Cobo M, Santas E, Verbrugge FH, Fudim M, Girerd N, Miñana G, Górriz JL, Bayés-Genís A, Núñez J. de la Espriella R, et al. Among authors: girerd n. Rev Esp Cardiol (Engl Ed). 2023 Jan;76(1):47-57. doi: 10.1016/j.rec.2022.07.009. Epub 2022 Aug 4. Rev Esp Cardiol (Engl Ed). 2023. PMID: 35934293 Review. English, Spanish.